WO1996035788A3 - Peptides inhibiteurs de proteases de type kunitz - Google Patents
Peptides inhibiteurs de proteases de type kunitz Download PDFInfo
- Publication number
- WO1996035788A3 WO1996035788A3 PCT/US1996/006384 US9606384W WO9635788A3 WO 1996035788 A3 WO1996035788 A3 WO 1996035788A3 US 9606384 W US9606384 W US 9606384W WO 9635788 A3 WO9635788 A3 WO 9635788A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- analogues
- kpi
- protease inhibitors
- type protease
- kunitz type
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8534170A JPH11504938A (ja) | 1995-05-08 | 1996-05-08 | クニッツ型プロテアーゼ阻害因子 |
AU58540/96A AU5854096A (en) | 1995-05-08 | 1996-05-08 | Kunitz type protease inhibitors |
EP96920140A EP0827539A2 (fr) | 1995-05-08 | 1996-05-08 | Peptides inhibiteurs de proteases de type kunitz |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43655595A | 1995-05-08 | 1995-05-08 | |
US64373196A | 1996-05-06 | 1996-05-06 | |
US08/436,555 | 1996-05-06 | ||
US08/643,731 | 1996-05-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996035788A2 WO1996035788A2 (fr) | 1996-11-14 |
WO1996035788A3 true WO1996035788A3 (fr) | 1996-12-12 |
Family
ID=27031013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/006384 WO1996035788A2 (fr) | 1995-05-08 | 1996-05-08 | Peptides inhibiteurs de proteases de type kunitz |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0827539A2 (fr) |
JP (1) | JPH11504938A (fr) |
KR (1) | KR19990008458A (fr) |
AU (1) | AU5854096A (fr) |
CA (1) | CA2220497A1 (fr) |
WO (1) | WO1996035788A2 (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8921314B2 (en) | 2008-10-15 | 2014-12-30 | Angiochem, Inc. | Conjugates of GLP-1 agonists and uses thereof |
US9161988B2 (en) | 2009-07-02 | 2015-10-20 | Angiochem Inc. | Multimeric peptide conjugates and uses thereof |
US9173891B2 (en) | 2009-04-20 | 2015-11-03 | Angiochem, Inc. | Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog |
US9221867B2 (en) | 2003-01-06 | 2015-12-29 | Angiochem Inc. | Method for transporting a compound across the blood-brain barrier |
US9365634B2 (en) | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5663143A (en) * | 1988-09-02 | 1997-09-02 | Dyax Corp. | Engineered human-derived kunitz domains that inhibit human neutrophil elastase |
US6057287A (en) | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
HU226419B1 (en) | 1996-03-11 | 2008-12-29 | Aerovance | Human bikunin |
AU4207499A (en) * | 1998-05-28 | 1999-12-13 | Zymogenetics Inc. | Kunitz domain polypeptide and materials and methods for making it |
JP2002517197A (ja) * | 1998-06-03 | 2002-06-18 | サイオス,インコーポレーテッド | プロテアーゼインヒビターペプチド |
US7153829B2 (en) | 2002-06-07 | 2006-12-26 | Dyax Corp. | Kallikrein-inhibitor therapies |
PT2311432E (pt) | 2002-06-07 | 2015-02-09 | Dyax Corp | Polipeptídeos de domínio kunitz modificado e sua utilização para a redução de isquemia ou aparecimento de uma resposta inflamatória sistémica associada a um procedimento cirúrgico |
US7235530B2 (en) | 2004-09-27 | 2007-06-26 | Dyax Corporation | Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
DK2360258T3 (en) | 2005-02-18 | 2015-01-12 | Angiochem Inc | Aprotininpolypeptider to transport a compound of blood-brain-barrier |
EP1907009A4 (fr) | 2005-07-15 | 2009-09-02 | Angiochem Inc | Utilisation de polypeptides de l'aprotinine comme vehicules dans des conjugues pharmaceutiques |
CN101952309A (zh) * | 2007-12-21 | 2011-01-19 | Ifxa有限公司 | 蛋白酶抑制剂 |
AU2009322043A1 (en) | 2008-12-05 | 2011-07-07 | Angiochem Inc. | Conjugates of neurotensin or neurotensin analogs and uses thereof |
AU2010203712A1 (en) | 2009-01-06 | 2010-07-15 | Dyax Corp. | Treatment of mucositis with kallikrein inhibitors |
LT2521568T (lt) | 2010-01-06 | 2018-12-10 | Dyax Corp. | Plazmos kalikreiną surišantys baltymai |
CN105713092B (zh) | 2011-01-06 | 2019-09-10 | 戴埃克斯有限公司 | 血浆前激肽释放酶结合蛋白 |
EP2885318A4 (fr) | 2012-08-14 | 2016-03-30 | Angiochem Inc | Conjugués peptides-dendrimères et leurs utilisations |
DK3307326T3 (da) | 2015-06-15 | 2020-10-19 | Angiochem Inc | Fremgangsmåder til behandling af leptomeningeal karcinomatose |
CN108699134A (zh) * | 2015-12-10 | 2018-10-23 | 国家生物技术研究所公司 | 淀粉样β-蛋白前体抑制剂结构域的变体 |
AU2016366557B2 (en) | 2015-12-11 | 2024-01-25 | Takeda Pharmaceutical Company Limited | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack |
CN110051830A (zh) * | 2019-03-14 | 2019-07-26 | 苏州新凝生物医药科技有限公司 | 一种protease nexin II\KPI蛋白突变体的应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0393431A1 (fr) * | 1989-04-18 | 1990-10-24 | Bayer Ag | Homologues de l'inhibiteur de la protéase d'Alzheimer préparés de manière génétique, des souches hôtes et vecteurs d'expression pour leur préparation et leur utilisation comme médicament |
WO1993014119A1 (fr) * | 1992-01-07 | 1993-07-22 | Novo Nordisk A/S | Variants inhibiteurs de type kunitz de la protease humaine |
WO1993014120A1 (fr) * | 1992-01-07 | 1993-07-22 | Novo Nordisk A/S | Variant inhibiteur de la protease humaine de type kunitz |
WO1995023860A2 (fr) * | 1994-03-04 | 1995-09-08 | Genentech, Inc. | PROTEINES INHIBITRICES PROPRES AU DOMAINE DE KÜNITZ DERIVEES DE L'INHIBITEUR DU PRECURSEUR DE LA β-PROTEINE AMYLOIDE DE LA MALADIE D'ALZHEIMER |
-
1996
- 1996-05-08 AU AU58540/96A patent/AU5854096A/en not_active Abandoned
- 1996-05-08 CA CA002220497A patent/CA2220497A1/fr not_active Abandoned
- 1996-05-08 KR KR1019970707988A patent/KR19990008458A/ko not_active Application Discontinuation
- 1996-05-08 WO PCT/US1996/006384 patent/WO1996035788A2/fr not_active Application Discontinuation
- 1996-05-08 JP JP8534170A patent/JPH11504938A/ja not_active Ceased
- 1996-05-08 EP EP96920140A patent/EP0827539A2/fr not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0393431A1 (fr) * | 1989-04-18 | 1990-10-24 | Bayer Ag | Homologues de l'inhibiteur de la protéase d'Alzheimer préparés de manière génétique, des souches hôtes et vecteurs d'expression pour leur préparation et leur utilisation comme médicament |
WO1993014119A1 (fr) * | 1992-01-07 | 1993-07-22 | Novo Nordisk A/S | Variants inhibiteurs de type kunitz de la protease humaine |
WO1993014120A1 (fr) * | 1992-01-07 | 1993-07-22 | Novo Nordisk A/S | Variant inhibiteur de la protease humaine de type kunitz |
WO1995023860A2 (fr) * | 1994-03-04 | 1995-09-08 | Genentech, Inc. | PROTEINES INHIBITRICES PROPRES AU DOMAINE DE KÜNITZ DERIVEES DE L'INHIBITEUR DU PRECURSEUR DE LA β-PROTEINE AMYLOIDE DE LA MALADIE D'ALZHEIMER |
Non-Patent Citations (7)
Title |
---|
DENNIS M S ET AL: "Kunitz domain inhibitors of tissue factor-factor VIIa: I. Potent inhibitors selected from libraries by phage display.", JOURNAL OF BIOLOGICAL CHEMISTRY 269 (35). 1994. 22129-22136. ISSN: 0021-9258, XP002015893 * |
DENNIS M S ET AL: "Kunitz domain inhibitors of tissue factor-factor VIIa: II. Potent and specific inhibitors by competitive phage selection.", JOURNAL OF BIOLOGICAL CHEMISTRY 269 (35). 1994. 22137-22144. ISSN: 0021-9258, XP002015892 * |
DENNIS M S ET AL: "Potent and Selective Kunitz Domain Inhibitors of Plasma Kallikrein Designed by Phage Display.", JOURNAL OF BIOLOGICAL CHEMISTRY 270 (43). 1995. 25411-25417. ISSN: 0021-9258, XP002015896 * |
HYNES T R ET AL: "X-RAY CRYSTAL STRUCTURE OF THE PROTEASE INHIBITOR DOMAIN OF ALZHEIMER 'S AMYLOID BETA-PROTEIN PRECURSOR.", BIOCHEMISTRY 29 (43). 1990. 10018-10022. CODEN: BICHAW ISSN: 0006-2960, XP002015891 * |
J. PERONA ET AL: "Crystal structures of rat anionic trypsin complexed with the protein inhibitors APPI and BPTI", JOURNAL OF MOLECULAR BIOLOGY, vol. 230, 1993, pages 919 - 933, XP000608106 * |
KIDO H ET AL: "PROTEASE-SPECIFICITY OF KUNITZ INHIBITOR DOMAIN OF ALZHEIMER 'S DISEASE AMYLOID PROTEIN PRECURSOR.", BIOCHEM BIOPHYS RES COMMUN 167 (2). 1990. 716-721. CODEN: BBRCA9 ISSN: 0006-291X, XP002015895 * |
S. SINHA ET AL: "Conversion of the Alzheimer's beta-Amyloid precursor protein (APP) Kunitz domain into a potent human neutrophil elastase inhibitor", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 266, no. 31, 5 November 1991 (1991-11-05), MD US, pages 21011 - 21013, XP002015894 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9221867B2 (en) | 2003-01-06 | 2015-12-29 | Angiochem Inc. | Method for transporting a compound across the blood-brain barrier |
US9365634B2 (en) | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
US8921314B2 (en) | 2008-10-15 | 2014-12-30 | Angiochem, Inc. | Conjugates of GLP-1 agonists and uses thereof |
US9173891B2 (en) | 2009-04-20 | 2015-11-03 | Angiochem, Inc. | Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog |
US9161988B2 (en) | 2009-07-02 | 2015-10-20 | Angiochem Inc. | Multimeric peptide conjugates and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
CA2220497A1 (fr) | 1996-11-14 |
EP0827539A2 (fr) | 1998-03-11 |
KR19990008458A (ko) | 1999-01-25 |
WO1996035788A2 (fr) | 1996-11-14 |
JPH11504938A (ja) | 1999-05-11 |
AU5854096A (en) | 1996-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996035788A3 (fr) | Peptides inhibiteurs de proteases de type kunitz | |
Janoff | Inhibition of human granulocyte elastase by serum α 1-antitrypsin | |
DE59007737D1 (de) | Proteinaseninhibitoren, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel. | |
TR199902692T2 (xx) | Serin proteaz inhibit�rleri. | |
CA2058935A1 (fr) | Compositions pharmaceutiques et methode de traitement a l'aide de peptides amyloides d'alzheimer | |
CA2421548A1 (fr) | Inhibiteurs amidine des serines proteases | |
Yarovaya et al. | Contact system. New concepts on activation mechanisms and bioregulatory functions | |
WO2003066824A3 (fr) | Peptides du domaine kunitz fusionnes a l'albumine | |
SE0201976D0 (sv) | Novel compounds | |
NO983688L (no) | Serin-protease-inhibitorer | |
WO1999063090A3 (fr) | Peptides inhibiteurs de protease | |
AU639257B2 (en) | Proteins having anticoagulant properties | |
Flight et al. | Comparison of textilinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents | |
NZ319474A (en) | Guanidino protease inhibitors | |
Schapira et al. | Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment. | |
V. Oliva et al. | Synthetic peptides and fluorogenic substrates related to the reactive site sequence of Kunitz-type inhibitors isolated from Bauhinia: interaction with human plasma kallikrein | |
Schoenberger et al. | Limited proteolysis of Cl‐inhibitor by chymotrypsin‐like proteinases | |
DK0833848T3 (da) | Faktor IX-bindende peptider afledt af faktor VIII og anvendelse heraf som inhibitorer af blodkoagulation | |
Ripka | Design of antithrombotic agents directed at factor Xa | |
Sulikowski et al. | α1‐Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1 | |
JP2839825B2 (ja) | 新規トリプシン様酵素 | |
Sugawara et al. | Human α-and γ-thrombin inhibition by trypsin inhibitors supports predictions from molecular graphics experiments | |
Schmaier | Gene expression, regulation and cell surface presentation of the kininogens | |
Steinbuch | Regulation of protease activity | |
BR0212122A (pt) | Arginais de peptìdeo e métodos para tratamento de coagulação intravascular disseminada |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2220497 Country of ref document: CA Ref country code: CA Ref document number: 2220497 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019970707988 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1996 534170 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996920140 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996920140 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970707988 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019970707988 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996920140 Country of ref document: EP |